Section Arrow
CYBN.NYSE-M
- Cybin Inc
Quotes are at least 15-min delayed:2025/09/04 02:29 EDT
Regular Hours
Last
 6.01
-0.23 (-3.69%)
Day High 
6.58 
Prev. Close
6.24 
1-M High
7.88 
Volume 
1.33M 
Bid
6
Ask
6.1
Day Low
5.81 
Open
6.57 
1-M Low
6.15 
Market Cap 
147.20M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 7.1 
20-SMA 7.24 
50-SMA 7.6 
52-W High 13.88 
52-W Low 4.81 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-6.15/-4.04
Enterprise Value
147.20M
Balance Sheet
Book Value Per Share
4.67
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PMNProMIS Neurosciences0.4574-0.0792-14.76%6.98PE
ADAPAdaptimmune Therapeutics plc0.0526-0.0052-9.00%-- 
CARMCarisma Therapeutics0.3699-0.0701-15.93%-- 
ETHZETHZilla Corporation2.52-0.15-5.62%-- 
STTKShattuck Labs1.28+0.27+26.73%-- 
Quotes are at least 15-min delayed:2025/09/04 02:29 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of itsproprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.